Superworth

Beta Bionics revenue BBNX

Sales by quarter and over the last twelve months, from 2024.

Last 12 months, to Sep 30, 2026
$127.3M
Latest quarter, Q3 FY26
$35.5M
+30% on a year earlier
Fiscal year 2025
$100.3M
+54% on the year before

Beta Bionics' revenue was $127.3M over the twelve months to Sep 30, 2026, up 44% on a year earlier.

In its latest quarter, Q3 FY26, it was $35.5M, up 30% on the same quarter a year before.

Revenue over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearRevenueChange
FY2025$100.3M+54%
FY2024$65.1Mn/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedRevenueOn a year earlierLast 12 months
Q3 FY26$35.5M+30%$127.3M
Q2 FY26$32M+38%$119M
Q1 FY26$27.6M+57%$110.2M
Q4 FY25$32.1M+57%$100.3M
Q3 FY25$27.3M+63%$88.6M
Q2 FY25$23.2M+54%$78M
Q1 FY25$17.6M+36%$69.8M
Q4 FY24$20.4Mn/a$65.1M
Q3 FY24$16.7Mn/an/a
Q2 FY24$15Mn/an/a
Q1 FY24$12.9Mn/an/a

Against its peers

Companies in Medical - Instruments & Supplies nearest Beta Bionics' size, closest first, today.

CompanyRevenue, 12 monthsGrowth
BBNXBeta Bionics$127.3M+44% a year
IRMDIradimed$89.3M+11% a year
MOVMovado$689.9M+5% a year
IARTIntegra Lifesciences$1.7B+1% a year
BVSBioventus$581.8M+4% a year
STAAStaar Surgical$339.6M+51% a year
CDRECadre$685.6M+20% a year
EYENational Vision$2B+8% a year
TCMDTactile Systems Technology$350.3M+17% a year
LMATLemaitre Vascular$262.4M+12% a year
INSPInspire Medical Systems$898.7M−0% a year
Peer median$633.7M

Where Beta Bionics ranks

What the revenue tells you

Total sales in the period. On the company page, quarterly bars or the trailing twelve months (TTM), which smooths seasonality.

Growing revenue with shrinking margins is a warning, not a win.

More on Beta Bionics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.